• Jounce faces hostile takeover bid from minority stakeholder

    15 days ago - By San Diego Biotechnology

    Cancer biotech Jounce Therapeutics has gotten a hostile takeover bid from Concentra Biosciences, a San Diego company backed by Tang Capital Partners. Tang Capital is also a shareholder in Jounce, owning just over 10% of...
    Read more ...